Literature DB >> 24351512

Post liver transplantation lymphoproliferative disorder mimics recurrence of hepatocellular carcinoma.

Kittiyod Poovorawan1, Sittikorn Linlawan, Naruemon Wisedopas, Piyawat Komolmit.   

Abstract

We report a case of Epstein-Barr virus (EBV)-related postliver transplantation lymphoproliferative disorder (PTLD) in a patient with post liver transplant which initially presented in a CT scan image mimicking recurrence of hepatocellular carcinoma. Histopathology showed atypical plasma cell-like infiltration, and immunohistochemistry confirmed diagnosis of EBV-associated diffuse large B-cell lymphoma. Typical imaging from dynamic phases contrast CT scan might not accurately diagnose recurrent HCC in postorthotropic liver transplantation. Liver biopsy should be performed for accurate diagnosis and proper treatment.

Entities:  

Mesh：

Year:  2013        PMID： 24351512      PMCID： PMC3888532          DOI： 10.1136/bcr-2013-200837

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  10 in total

Review 1.  Epstein-Barr virus infection.

Authors:  J I Cohen
Journal:  N Engl J Med       Date:  2000-08-17       Impact factor: 91.245

2.  Organ Procurement and Transplantation Network and Scientific Registry of Transplant Recipients 2010 data report.

Authors: 
Journal:  Am J Transplant       Date:  2011-11-22       Impact factor: 8.086

3.  Epstein-barr virus and posttransplant lymphoproliferative disorder in solid organ transplant recipients.

Authors:  U Allen; J Preiksaitis
Journal:  Am J Transplant       Date:  2009-12       Impact factor: 8.086

4.  Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study.

Authors:  Sylvain Choquet; Veronique Leblond; Raoul Herbrecht; Gérard Socié; Anne-Marie Stoppa; Peter Vandenberghe; Alain Fischer; Franck Morschhauser; Gilles Salles; Walter Feremans; Etienne Vilmer; Marie-Noelle Peraldi; Philippe Lang; Yvon Lebranchu; Eric Oksenhendler; Jeanne Luce Garnier; Thierry Lamy; Arnaud Jaccard; Augustin Ferrant; Fritz Offner; Olivier Hermine; Anne Moreau; Samira Fafi-Kremer; Patrice Morand; Lucienne Chatenoud; Nathalie Berriot-Varoqueaux; Loïc Bergougnoux; Noel Milpied
Journal:  Blood       Date:  2005-10-27       Impact factor: 22.113

5.  Enlarged lymph nodes in the upper abdomen after liver transplantation: imaging features and clinical significance.

Authors:  C Valls; S Ruiz; L Martinez; D Leiva; J Busquets; T Serrano; J Fabregat
Journal:  Radiol Med       Date:  2011-06-04       Impact factor: 3.469

6.  Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation.

Authors:  D W Hanto; G Frizzera; K J Gajl-Peczalska; K Sakamoto; D T Purtilo; H H Balfour; R L Simmons; J S Najarian
Journal:  N Engl J Med       Date:  1982-04-15       Impact factor: 91.245

7.  Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease.

Authors:  Françoise Smets; Dominique Latinne; Hervé Bazin; Raymond Reding; Jean-Bernard Otte; Jean-Paul Buts; Etienne M Sokal
Journal:  Transplantation       Date:  2002-05-27       Impact factor: 4.939

8.  De novo cancer occurrence after renal transplantation: a medical center experience in Taiwan.

Authors:  Y-J Chiang; C-H Chen; C-T Wu; S-H Chu; Y Chen; K-L Liu; S-W Chen; C-K Chuang
Journal:  Transplant Proc       Date:  2004-09       Impact factor: 1.066

9.  Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era.

Authors:  Andrew M Evens; Kevin A David; Irene Helenowski; Beverly Nelson; Dixon Kaufman; Sheetal M Kircher; Alla Gimelfarb; Elise Hattersley; Lauren A Mauro; Borko Jovanovic; Amy Chadburn; Patrick Stiff; Jane N Winter; Jayesh Mehta; Koen Van Besien; Stephanie Gregory; Leo I Gordon; Jamile M Shammo; Scott E Smith; Sonali M Smith
Journal:  J Clin Oncol       Date:  2010-01-19       Impact factor: 44.544

Review 10.  Epstein-Barr virus infection and posttransplant lymphoproliferative disorder.

Authors:  M Green; M G Michaels
Journal:  Am J Transplant       Date:  2013-02       Impact factor: 8.086
  10 in total
  1 in total

1.  Early Onset Post-transplant Lymphoproliferative Disorder Presenting with Diarrhea Post-orthotopic Liver Transplant Treated Successfully with Single Rituximab Agent.

Authors:  Bonnie Patek; Cristina Strahotin
Journal:  Cureus       Date:  2019-11-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.